Money Talks News on MSN9d
This Vaccine Is Now Tied to a 17% Lower Dementia Risk
Getting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...
Fierce Biotech8d
GSK takes advantage of natural experiment to study whether shingles vaccine can reduce dementia risk
After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...
BioSpace7d
GSK Builds on Real-World Experiment to Study Shingrix’s Impact on Dementia
The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...
Medscape13d
Recombinant Zoster Vaccine Proved Effective in Patients With Rheumatoid Arthritis
The recombinant zoster vaccine is effective in preventing herpes zoster in adults aged 50 years or older with rheumatoid ...
Daily Mail3d
Does the shingles jab slash your risk of dementia? Drugs giant GSK launches ground-breaking study that could save millions of Brits from developing the disease
The four-year project will seek to confirm mounting evidence the Shingrix vaccine – already available on the NHS – cuts the risk of dementia by up to 27 per cent compared with an older ...
valuepenguin5d
Medicare and the Shingles Vaccine: Are You Covered?
If you don't have Medicare prescription drug coverage or you don't yet qualify for Medicare, the full price for two doses of the Shingrix vaccine is $367. The shingles vaccine is free for nearly ...
Reuters8d
GSK studying if best-selling shingles vaccine lowers dementia risk
When the national vaccine programme expanded in 2023, 65-year-olds upwards became eligible for the Shingrix vaccine, whereas previously only people aged 70 and over were eligible. However ...